Navigation Links
Intraspinal implant of mesenchymal stem cells may not heal the demyelinated spinal cord
Date:11/12/2008

Tampa, Fla. (Nov. 12, 2008) Multiple sclerosis is a disease caused by the loss of the myelinated sheath surrounding the nerve fibers of the spinal cord. Therapeutic hope for curing multiple sclerosis and other demyelinating diseases has included the possibility that stem cell transplants could help remyelinate the spinal cord. Accordingly, researchers from the University of Cambridge (UK) conducted experiments using animal models to see if the direct implantation of multipotent mesenchymal stem cells (MSCs) (derived from a different rat's adult bone marrow, i.e. allogenic) into the demyelinated rat spinal cord would be therapeutic and remyelinate the damaged area.

"MSCs are attractive candidates for cell-based therapies because of their ease of isolation, expansion and potential for autologous application," said Dr. David Hunt, of the Centre for Brain Repair at the University of Cambridge. "A number of in vitro and in vivo studies have reported that MSCs have differentiated into neuronal cells and Schwann cells as well as fat cells and bone cells. Our study showed that direct, intralesional injection of undifferentiated MSCs did not lead to remyelination. Once more, we found that the MSCs migrated into areas of normal tissue and were associated with axonal damage."

Despite the disappointing results of this study, Dr. Hunt feels that further experimentation with directly implanted MSCs is still called for since a variety of other MSC populations, such as autologous cells whereby the donor and recipient are the same organism, have been used in experimental and clinical settings with some degree of success.

"Our results contrast with previously published reports that demonstrated robust Schwann cell remyelination after bone marrow stromal cell injection," reported Dr. Hunt. "An important difference in results may lie in the distinct methodologies used to culture MSCs."

Although MSCs may possess neural differentiation capabilities in vitro, their in vivo behavior is unpredictable, said Dr. Hunt and his co-authors. However, they agree that MSCs should still be considered a promising tool for treating neurological disorders because they have shown pre-clinical efficacy for treating stroke and MS when injected intravenously with the ability to migrate to areas of inflammation and tissue damage and appear to exert a tissue protective effect through a range of mechanisms including immune modulation.

"This work demonstrates how important the route of administration and the culture conditions are when considering the efficacy and safety of a stem cell therapy," said Dr. Paul Sanberg, Distinguished Professor at University of South Florida Health and coeditor-in-chief of Cell Transplantation.


'/>"/>

Contact: Dr. David Hunt
dpjh2@cam.ac.uk
01-223-331-160
Cell Transplantation Center of Excellence for Aging and Brain Repair
Source:Eurekalert

Related biology news :

1. TECNALIA investigates advanced biomaterials to make more reliable and hardwearing medical implants
2. NC State finds new nanomaterial could be breakthrough for implantable medical devices
3. Researchers design artificial cells that could power medical implants
4. Project aims to reduce complications, multiple surgeries with biodegradable implantable devices
5. Implanting embryonic cardiac cells prevents arrhythmias
6. Layered approach may yield stronger, more successful bone implants
7. In the war against diseases, nerve cells need their armor
8. MIT creates tiny backpacks for cells
9. Scripps research scientists identify compounds for stem-cell production from adult cells
10. Lung airway cells activate vitamin D and increase immune response
11. New method provides panoramic view of protein-RNA interactions in living cells
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/10/2020)... WORCESTER, Mass. (PRWEB) , ... February 10, 2020 ... ... created and unveiled a structural 3D roadmap of the new coronavirus (2019-nCoV), a ... of the deadly virus. , Using a recently published viral genome of the ...
(Date:2/5/2020)... BROOMFIELD, Colo. (PRWEB) , ... February 04, 2020 ... ... Patent and Trademark Office (USPTO) issued the company a second patent related to ... The Notice of Allowance compliments another patent from the USPTO issued on December ...
(Date:1/29/2020)... N.C. (PRWEB) , ... January 29, 2020 , ... ... to lead the new Analytics and Data Sciences practice, providing consulting services for ... Burke’s appointment was announced by Mike Townley, co-founder and Managing Partner of CREO, ...
Breaking Biology News(10 mins):
(Date:1/8/2020)... ... January 08, 2020 , ... Anomet Products ... properties for use in harsh environments inside or outside of the human body. ... metals or alloys to achieve specific properties such as corrosion-resistance, biocompatibility, or operation ...
(Date:1/7/2020)... N.J. (PRWEB) , ... January 07, 2020 , ... Vuja ... prevent cancer progression and recurrence, today announced the appointments of Chand Khanna, DVM, PhD, ... Co-founder and CEO of Vuja De said, “We are delighted to welcome Chand and ...
(Date:1/7/2020)... (PRWEB) , ... January 06, 2020 , ... ... announced the second cohort of emerging biosciences ventures invited to participate in the ... education to develop fundable business plans and a professional network. All startups will ...
(Date:12/30/2019)... HARBOR TOWNSHIP, N.J. (PRWEB) , ... December 30, ... ... manufacturer of custom built, helium-based leak testing instruments for the Pharmaceutical, Biotechnology, Medical ... new SIMS Version 1.11.19 21 CFR Part 11 compliant software program specific to ...
Breaking Biology Technology: